AtriCure had a negative net margin of 8.70% and a negative return on equity of 8.12%. The business had revenue of $115.91 million for the quarter, compared to analysts’ expectations of $112.23 ...

JPMorgan analyst Lilia-Celine Lozada assumed coverage of AtriCure (ATRC) with an Overweight rating and $40 price target With numbers reset and competitive headwinds not materializing as feared ...

Pipeline for particle picking in cryo-electron microscopy images using convolutional neural networks trained from positive and unlabeled examples. Also featuring micrograph and tomogram denoising with ...

UK-based company Real Ice has an ambitious plan to combat global warming: refreezing the Arctic Sea. Specifically, it plans to pump ocean water on top of ice caps to help them grow thicker.

Shoulder seasons is when it is most unsafe Lake ice formation in the Northern Hemisphere could be delayed anywhere from Nov. 15 to Jan. 18, dictated by how high average temperatures climb—1°C ...

加拿大投资银行集团：维持AtriCure(ATRC.US)评级，由买入调整至买入评级,目标价由53.00美元调整至61.00美元。 AtriCure(ATRC.US)公司简介：AtriCure,Inc..从事心脏组织手术消融和左心房附件排除系统的开发、制造和销售。其产品包括射频(RF)消融起搏器和传感，冷冻 ...

State Key Laboratory of Molecular Engineering of Polymers and Department of Macromolecular Science, Fudan University, Shanghai 200438, China ...

In the latest quarter, 6 analysts provided ratings for AtriCure (NASDAQ ... Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others.

Canaccord analyst William Plovanic raised the firm’s price target on AtriCure (ATRC) to $61 from $53 and keeps a Buy rating on the shares. Canaccord said they are bullish on the Med-Tech sector ...